160 related articles for article (PubMed ID: 8546904)
1. Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells.
Kawamura KI; Grabowski D; Weizer K; Bukowski R; Ganapathi R
Br J Cancer; 1996 Jan; 73(2):183-8. PubMed ID: 8546904
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mitosis by okadaic acid: possible involvement of a protein phosphatase 2A in the transition from metaphase to anaphase.
Vandré DD; Wills VL
J Cell Sci; 1992 Jan; 101 ( Pt 1)():79-91. PubMed ID: 1314839
[TBL] [Abstract][Full Text] [Related]
3. The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics.
Okouneva T; Hill BT; Wilson L; Jordan MA
Mol Cancer Ther; 2003 May; 2(5):427-36. PubMed ID: 12748304
[TBL] [Abstract][Full Text] [Related]
4. Selective enhancement of vincristine cytotoxicity in multidrug-resistant tumor cells by dilantin (phenytoin).
Ganapathi R; Hercbergs A; Grabowski D; Ford J
Cancer Res; 1993 Jul; 53(14):3262-5. PubMed ID: 8100737
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid.
Inomata M; Saijo N; Kawashima K; Kaneko A; Fujiwara Y; Kunikane H; Tanaka Y
J Cancer Res Clin Oncol; 1995; 121(12):729-38. PubMed ID: 7499444
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance.
Chambers TC; Raynor RL; Kuo JF
Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882
[TBL] [Abstract][Full Text] [Related]
7. Okadaic acid inhibits a protein phosphatase activity involved in formation of the mitotic spindle of GH4 rat pituitary cells.
Van Dolah FM; Ramsdell JS
J Cell Physiol; 1992 Jul; 152(1):190-8. PubMed ID: 1320037
[TBL] [Abstract][Full Text] [Related]
8. A new bis-indole, KARs, induces selective M arrest with specific spindle aberration in neuroblastoma cell line SH-SY5Y.
Comín-Anduix B; Agell N; Bachs O; Ovádi J; Cascante M
Mol Pharmacol; 2001 Dec; 60(6):1235-42. PubMed ID: 11723230
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma.
Hutson TE; Ganapathi R; Elson P; Mekhail T; Olencki T; Budd GT; Bukowski RM
Invest New Drugs; 2004 Aug; 22(3):277-84. PubMed ID: 15122074
[TBL] [Abstract][Full Text] [Related]
10. Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2Aalpha.
Bonness K; Aragon IV; Rutland B; Ofori-Acquah S; Dean NM; Honkanen RE
Mol Cancer Ther; 2006 Nov; 5(11):2727-36. PubMed ID: 17121919
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine.
Ngan VK; Bellman K; Hill BT; Wilson L; Jordan MA
Mol Pharmacol; 2001 Jul; 60(1):225-32. PubMed ID: 11408618
[TBL] [Abstract][Full Text] [Related]
12. DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells.
Li H; Sun L; Li H; Lv X; Semukunzi H; Li R; Yu J; Yuan S; Lin S
Cell Death Dis; 2017 May; 8(5):e2810. PubMed ID: 28542137
[TBL] [Abstract][Full Text] [Related]
13. Mitotic arrest and enhanced nuclear protein phosphorylation in human leukemia K562 cells by okadaic acid, a potent protein phosphatase inhibitor and tumor promoter.
Zheng B; Woo CF; Kuo JF
J Biol Chem; 1991 Jun; 266(16):10031-4. PubMed ID: 1645333
[TBL] [Abstract][Full Text] [Related]
14. Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.
Zheng B; Chambers TC; Raynor RL; Markham PN; Gebel HM; Vogler WR; Kuo JF
J Biol Chem; 1994 Apr; 269(16):12332-8. PubMed ID: 7512966
[TBL] [Abstract][Full Text] [Related]
15. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
Chambers TC; Zheng B; Kuo JF
Mol Pharmacol; 1992 Jun; 41(6):1008-15. PubMed ID: 1377325
[TBL] [Abstract][Full Text] [Related]
16. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
[TBL] [Abstract][Full Text] [Related]
17. Polyoxyethylene 40 stearate modulates multidrug resistance and enhances antitumor activity of vinblastine sulfate.
Luo L; Xu X; Shi B; Wu J; Hu Y
AAPS J; 2007 Oct; 9(3):E329-35. PubMed ID: 18170979
[TBL] [Abstract][Full Text] [Related]
18. Effects of okadaic acid on mitotic HeLa cells.
Ghosh S; Paweletz N; Schroeter D
J Cell Sci; 1992 Sep; 103 ( Pt 1)():117-24. PubMed ID: 1331133
[TBL] [Abstract][Full Text] [Related]
19. Treatment of myeloid leukemic cells with the phosphatase inhibitor okadaic acid induces cell cycle arrest at either G1/S or G2/M depending on dose.
Ishida Y; Furukawa Y; Decaprio JA; Saito M; Griffin JD
J Cell Physiol; 1992 Mar; 150(3):484-92. PubMed ID: 1311329
[TBL] [Abstract][Full Text] [Related]
20. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
Dumontet C; Jaffrezou JP; Tsuchiya E; Duran GE; Chen KG; Derry WB; Wilson L; Jordan MA; Sikic BI
Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
